Valeant Pharmaceuticals Intern...
NYSE: VRX
$23.40
-$0.83 (-3.4%)
Closing price July 13, 2018
The top analyst upgrades, downgrades and other research calls from Wednesday include Cree, Home Depot, Kimberly-Clark, Microsoft, Oracle, Valeant Pharmaceuticals and Valero Energy.
Published:
Last Updated:
Valeant Pharmaceuticals shares made a spectacular crash over the course of 2015 to 2017, and it looks like they may now be on the path to recovery.
Published:
Last Updated:
The include Delta Air Lines, Express Scripts, Form Factor, Marathon Oil, Under Armour and Valeant Pharmaceutical.
Published:
Last Updated:
Drug maker Valeant got a big profit boost from a one-time tax benefit and the company also boosted its EPS guidance and trimmed its revenue guidance for the full year.
Published:
Last Updated:
Most of the earnings season has come and gone but there are still some major companies posting results this week.
Published:
Last Updated:
24/7 Wall St. has collected a few pharma and biotech catalysts that are coming up on the calendar in November and December.
Published:
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) saw its shares make a handy gain on Thursday after the company provided an update from the U.S. Food and Drug Administration (FDA)....
Published:
Last Updated:
Valeant Pharmaceuticals reported mixed second-quarter financial results before the markets opened on Tuesday.
Published:
Last Updated:
24/7 Wall St. has put together a preview of a few major companies scheduled to report their quarterly results this coming week.
Published:
Last Updated:
Valeant Pharmaceuticals shares made a solid gain on Thursday after the company announced the sale of its iNova Pharmaceutical business.
Published:
Last Updated:
With earnings this positive and shares responding as a result, investors have to wonder if Valeant Pharmaceuticals is for real this time, or is this just a head fake.
Published:
Last Updated:
Canadian pharmaceutical maker Valeant posted a big beat on both earnings and revenues Tuesday morning. The company also raised its adjusted EBITDA guidance for the full fiscal year.
Published:
Last Updated:
24/7 Wall St. has put together a preview of Disney, Valeant Pharmaceuticals and a other major companies scheduled to report their quarterly results this coming week.
Published:
Last Updated:
Following the closing of the sale of three skincare brands to L'Oréal and after the closing of the divestiture of a manufacturing facility in Brazil, Valeant said that it now has further reduced its...
Published:
Last Updated:
Rite Aid, DryShips, Mattel, and Valeant all posted new 52-week lows on Monday.
Published:
Last Updated: